As digital health evolves, many people have become concerned about the potential limitations HIPAA places on technological advancements. Is...
New Episodes
View all
Due to Brexit, the Medicines and Healthcare products Regulatory Agency (MHRA) has had to develop its own procedures separate from the...
How can bioscience companies foster diversity within their industry? Join Darshan Kulkarni as he talks with entrepreneur Tia Lyles-Williams...
Life science company Verily has recently launched a new health insurance venture. How might this affect the healthcare industry? In today’s...
What is an FDA warning letter, and how should your company respond once it has received one? In today's episode, Darshan Kulkarni talks...
There is growing pressure being placed on pharmaceutical companies to make their clinical trials more transparent. Despite this pressure...